Status:
TERMINATED
Adult Growth Hormone Deficiency and Cardiovascular Risk
Lead Sponsor:
Columbia University
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
19-65 years
Phase:
PHASE4
Brief Summary
This protocol will assess the cardiovascular risk associated with growth hormone deficiency in adults. We will use multiple modalities to assess risk for heart attacks or strokes including blood work,...
Detailed Description
Subjects will first be tested for possible growth hormone deficiency. This will be done by administering two intravenous medications that should stimulate growth hormone secretion and we will measure ...
Eligibility Criteria
Inclusion
- Adults 19 years or older who have undergone transsphenoidal surgery for a clinically non-secreting pituitary adenoma
Exclusion
- Currently taking growth hormone, radiation therapy in the past 5 years, changes in dose of other pituitary hormone replacement therapy in past 3 months, taking hydrocortisone (or its equivalent) at a dose of \> 30 mg/day, pregnant or nursing women
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00720902
Start Date
February 1 2007
End Date
May 1 2011
Last Update
November 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University, College of Physicians and Surgeons
New York, New York, United States, 10032